Literature DB >> 11500620

Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis.

C Farina1, M Arosio, M Mangia, F Moioli.   

Abstract

Lactobacillus species are part of normal gastrointestinal flora and are an uncommon cause of bacteremia. Lactobacillus casei subsp. rhamnosus was repeatedly isolated in the blood cultures of a 43-year-old woman with ulcerative colitis. Lactobacillus spp. could be considered a potential opportunistic pathogen whenever there is disruption of the physiologic architecture of the intestinal mucosa, such as in abdominal surgery, endoscopic procedures, or enteric pathologies. Clinicians and clinical microbiologists need to be aware of this infective complication in patients with ulcerative colitis.

Entities:  

Mesh:

Year:  2001        PMID: 11500620     DOI: 10.1097/00004836-200109000-00019

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  17 in total

1.  Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

Authors:  P Marteau; M Lémann; P Seksik; D Laharie; J F Colombel; Y Bouhnik; G Cadiot; J C Soulé; A Bourreille; E Metman; E Lerebours; F Carbonnel; J L Dupas; M Veyrac; B Coffin; J Moreau; V Abitbol; S Blum-Sperisen; J Y Mary
Journal:  Gut       Date:  2005-12-23       Impact factor: 23.059

Review 2.  Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.

Authors:  J P Cannon; T A Lee; J T Bolanos; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

Review 3.  Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature.

Authors:  Simone Meini; Raffaele Laureano; Lucia Fani; Carlo Tascini; Angelo Galano; Alberto Antonelli; Gian Maria Rossolini
Journal:  Infection       Date:  2015-05-30       Impact factor: 3.553

4.  Lactobacillus rhamnosus bacteremia: an emerging clinical entity.

Authors:  F Gouriet; M Million; M Henri; P-E Fournier; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

Review 5.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

Review 6.  Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.

Authors:  Daisy Jonkers; John Penders; Ad Masclee; Marieke Pierik
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

7.  Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip.

Authors:  Woojung Shin; Hyun Jung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

Review 8.  The role of probiotics in inflammatory bowel disease.

Authors:  Jennifer L Jones; Amy E Foxx-Orenstein
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

Review 9.  Probiotics in inflammatory bowel diseases and associated conditions.

Authors:  David R Mack
Journal:  Nutrients       Date:  2011-02-17       Impact factor: 5.717

10.  Sepsis associated with Lactobacillus bacteremia in a patient with ischemic colitis.

Authors:  Hrishikesh S Kulkarni; Charbel C Khoury
Journal:  Indian J Crit Care Med       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.